Skip to Main Content

Paper Details

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
Eur Heart J
101
2021
Author NameAffiliation
William T AbrahamThe Ohio State University
JoAnn LindenfeldVanderbilt University Medical Center, 1211 Medical Center Drive
Akshay S DesaiBrigham and Women's Hospital and Harvard Medical School
Gerasimos FilippatosNational and Kapodistrian University of Athens
Gerasimos FilippatosUniversity of Cyprus, Shacolas Educational Centre for Clinical Medicine
  • 1 - 5

Datasets

Release 1.2